In Tuesday’s Wall Street session, Invesco Ltd (NYSE:IVZ) shares traded at $21.25, up 5.20% from the previous session.
IVZ stock price is now 35.10% away from the 50-day moving average and 28.74% away from the 200-day moving average. The market capitalization of the company currently stands at $9.51B.
With the price target maintained at $25, TD Cowen recently Upgraded its rating from Hold to Buy for Invesco Ltd (NYSE: IVZ). On July 11, 2025, Wells Fargo Upgraded its previous ‘Underweight’ rating to ‘Equal Weight’ on the stock keeping its target price maintained at $18, while ‘TD Cowen’ rates the stock as ‘Hold’
A total of 0.81% of the company’s stock is owned by insiders.
During the past 12 months, Invesco Ltd has had a low of $11.60 and a high of $20.63. As of last week, the company has a debt-to-equity ratio of 0.73, a current ratio of 0.27, and a quick ratio of 1.36. According to the stock market information, the enterprise value for the company is $14282937344, which is based on a 22.82 price-to-earnings ratio, a 2.00 price-to-earnings-growth ratio, and a beta of 1.50. The fifty day moving average price for IVZ is $15.7296 and a two-hundred day moving average price translates $16.50595 for the stock.
The latest earnings results from Invesco Ltd (NYSE: IVZ) was released for 2025-03-31. The net profit margin was 6.90% and return on equity was 5.74% for IVZ. The company reported revenue of $1.53 billion for the quarter, compared to $1.48 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 3.65 percent. For the current quarter, analysts expect IVZ to generate $1.16B in revenue.